Immunotherapy for cardiovascular disease

• Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial

  2025 JAMA Cardiology article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases

  58

  citations
• Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent manner

  2024 Cardiovascular Research article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access

  9

  citations
• Targeting immune cell recruitment in atherosclerosis

  2024 Nature Reviews Cardiology review Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases

  84

  citations
• Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosis

  2024 Nature Cardiovascular Research article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access

  34

  citations
• Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice

  2023 Science Translational Medicine article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access

  28

  citations
• Loss of myeloid cannabinoid CB1 receptor confers atheroprotection by reducing macrophage proliferation and immunometabolic reprogramming

  2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access

  2

  citations
• Gut Microbiota and Coronary Plaque Characteristics

  2022 Journal of the American Heart Association article Biochemistry, Genetics and Molecular Biology Gut microbiota and health Open access

  55

  citations
• Systemic Inflammation Is Associated With Future Risk of Fatal Infection: An Observational Cohort Study

  2022 The Journal of Infectious Diseases article Medicine Inflammatory Biomarkers in Disease Prognosis Open access

  18

  citations
• Targeting the CCL2–CCR2 axis for atheroprotection

  2022 European Heart Journal article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access

  170

  citations
• Low grade systemic inflammation is a risk factor for infection death: an observational cohort study

  2021 medRxiv preprint Medicine Inflammatory Biomarkers in Disease Prognosis Open access

  0

  citations

10 results